fainting on glp 1 GLP-1 and Low Blood Pressure: Symptoms, Risks, and Management GLP-1 Heart Palpitations: Safety, Causes

Oral semaglutide (Rybelsus) has also been approved for glycemic control in type 2 diabetes, providing a non-injectable option that supports broader patient acceptance

Preliminary studies have suggested that GLP-1 drugs might protect against or treat dementia and Alzheimers disease

Nevertheless, these evaluations often depend on short-term trial results projected across lifetime horizons, so injecting uncertainty over long-term efficacy and safety

A systematic review and meta-analysis published in BMC Gastroenterology found that constipation rates with GLP-1 receptor agonists were approximately 2.5 times higher than placebo groups

In addition, with rapid weight loss, many havent yet been able to put the necessary lifestyle habits in place to be successful at weight maintenance

Methods and Protocols